(Q40720226)

23 September 2017

TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells (English)

1 reference

23 September 2017

3

David B Agus

1 reference

23 September 2017

Sigal Gery

1

1 reference

23 September 2017

Charles L Sawyers

series ordinal

2

1 reference

23 September 2017

Jonathan W Said

series ordinal

4

1 reference

23 September 2017

H Phillip Koeffler

series ordinal

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

23 September 2017

8

1 reference

inferred from page(s)

published in

Oncogene

1 reference

23 September 2017

21

1 reference

23 September 2017

31

1 reference

23 September 2017

4739-4746

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205142

23 September 2017

0 references

cites work

Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Structure and function of epidermal growth factor-like regions in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Regulation of growth, PSA/PAP and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Vitamin D and prostate cancer: biologic interactions and clinical potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Functions of agrin and agrin-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

A tyrosine kinase profile of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

The role of vitamin D in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Chromosomal changes during development and progression of prostate adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

7 January 2021

inferred from DOI database lookup

Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

7 January 2021

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205142

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.ONC.1205142

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference